Achieved blood pressures in the secondary prevention of small subcortical strokes (SPS3) study: challenges and lessons learned.

PubWeight™: 0.97‹?› | Rank: Top 15%

🔗 View Article (PMC 4184404)

Published in Am J Hypertens on March 07, 2014

Authors

Pablo E Pergola1, Carole L White2, Jeff M Szychowski3, Robert Talbert4, Oscar Del Brutto5, Mar Castellanos6, John W Graves7, Gonzalo Matamala8, Edwin Javier Pretell9, Jerry Yee10, Rosario Rebello11, Yu Zhang3, Oscar R Benavente12, SPS3 Investigators

Author Affiliations

1: Department of Medicine, University of Texas Health Sciences Center at San Antonio and Renal Associates PA, San Antonio, Texas;
2: School of Nursing, University of Texas Health Sciences Center at San Antonio, San Antonio, Texas; whitec2@uthscsa.edu.
3: Department of Biostatistics, University of Alabama at Birmingham, Birmingham, Alabama;
4: College of Pharmacy, University of Texas at Austin, Austin, Texas;
5: Department of Neurological Sciences, Hospital-Clínica Kennedy, and School of Medicine, Universidad Espíritu Santo-Ecuador, Guayaquil, Ecuador;
6: Department of Neurology, Hospital Universitari Dr. Josep Trueta of Girona, Barcelona, Spain;
7: Division of Nephrology and Hypertension College of Medicine, Mayo Clinic, Rochester, Minnesota;
8: Unidad de Neurologia, Hospital Naval A. Nef, Vina del Mar, Chile;
9: Hospital Alberto Sabogal, Lima, Peru;
10: Nephrology and Hypertension, Henry Ford Hospital, Detroit, Michigan;
11: Department of Medicine, Dalhousie University, Halifax, Canada;
12: Division of Neurology, Department of Medicine, Brain Research Center, University of British Columbia, Vancouver, Canada.

Articles cited by this

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA (2003) 97.28

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet (2002) 23.18

Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med (2010) 21.49

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet (2001) 17.97

Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ (2009) 17.73

Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation (2011) 14.00

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet (2005) 12.92

Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension (2004) 11.95

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet (2004) 11.13

Cerebral vascular accidents in patients over the age of 60. II. Prognosis. Scott Med J (1957) 8.43

Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group. JAMA (2000) 7.73

Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertens (Greenwich) (2002) 6.03

Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial. Lancet (2013) 5.20

Racial disparities in hypertension prevalence, awareness, and management. Arch Intern Med (2005) 5.09

Atenolol in hypertension: is it a wise choice? Lancet (2004) 4.75

Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial. Lancet (2013) 4.57

Quality improvement strategies for hypertension management: a systematic review. Med Care (2006) 4.29

Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril. JAMA (2005) 3.89

Racial and geographic differences in awareness, treatment, and control of hypertension: the REasons for Geographic And Racial Differences in Stroke study. Stroke (2006) 3.67

Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review. Stroke (2003) 3.41

The Secondary Prevention of Small Subcortical Strokes (SPS3) study. Int J Stroke (2011) 2.35

Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Arch Intern Med (2005) 1.99

Effect of antihypertensive treatment in patients having already suffered from stroke. Gathering the evidence. The INDANA (INdividual Data ANalysis of Antihypertensive intervention trials) Project Collaborators. Stroke (1997) 1.54

Clinical features and racial/ethnic differences among the 3020 participants in the Secondary Prevention of Small Subcortical Strokes (SPS3) trial. J Stroke Cerebrovasc Dis (2012) 1.47

Medical treatment in acute and long-term secondary prevention after transient ischaemic attack and ischaemic stroke. Lancet (2011) 1.46

Protocol-based treatment of hypertension: a critical step on the pathway to progress. JAMA (2014) 1.30

Reliability and validity of blood pressure measurement in the Secondary Prevention of Small Subcortical Strokes study. Blood Press Monit (2007) 1.12

Awareness, treatment, and control of vascular risk factors among stroke survivors. J Stroke Cerebrovasc Dis (2010) 1.12

Understanding racial disparities in hypertension control: intensity of hypertension medication treatment in the REGARDS study. Ethn Dis (2007) 1.05

Impacting population cardiovascular health through a community-based practice network: update on an ASH-supported collaborative. J Clin Hypertens (Greenwich) (2011) 0.98

Prevalence of inadequate blood pressure control among veterans after acute ischemic stroke hospitalization: a retrospective cohort. Circ Cardiovasc Qual Outcomes (2011) 0.85

Blood pressure after recent stroke: baseline findings from the secondary prevention of small subcortical strokes trial. Am J Hypertens (2013) 0.85

Predictors of lowering SBP to assigned targets at 12 months in the Secondary Prevention of Small Subcortical Strokes study. J Hypertens (2012) 0.80

Why is controlling blood pressure after stroke so difficult? CMAJ (2012) 0.79

Effectiveness of a protocol-based strategy for achieving better blood pressure control in general practice. Fam Pract (2009) 0.78

Articles by these authors

Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. N Engl J Med (2012) 5.69

The Secondary Prevention of Small Subcortical Strokes (SPS3) study. Int J Stroke (2011) 2.35

Effects of long-term blood pressure lowering and dual antiplatelet treatment on cognitive function in patients with recent lacunar stroke: a secondary analysis from the SPS3 randomised trial. Lancet Neurol (2014) 1.51

Clinical features and racial/ethnic differences among the 3020 participants in the Secondary Prevention of Small Subcortical Strokes (SPS3) trial. J Stroke Cerebrovasc Dis (2012) 1.47

Reliability and validity of blood pressure measurement in the Secondary Prevention of Small Subcortical Strokes study. Blood Press Monit (2007) 1.12

Clinical-MRI correlations in a multiethnic cohort with recent lacunar stroke: the SPS3 trial. Int J Stroke (2014) 0.91

The correlates and course of depression in patients with lacunar stroke: results from the Secondary Prevention of Small Subcortical Strokes (SPS3) study. Cerebrovasc Dis (2011) 0.90

Blood pressure after recent stroke: baseline findings from the secondary prevention of small subcortical strokes trial. Am J Hypertens (2013) 0.85

Clinical correlates of infarct shape and volume in lacunar strokes: the Secondary Prevention of Small Subcortical Strokes trial. Stroke (2014) 0.81

Long-term disability after lacunar stroke: secondary prevention of small subcortical strokes. Neurology (2015) 0.81

Vertebrobasilar ectasia in patients with lacunar stroke: the secondary prevention of small subcortical strokes trial. J Stroke Cerebrovasc Dis (2015) 0.80

Should Blood Pressure Targets After Lacunar Stroke Vary by Body Size? The SPS3 Trial. Am J Hypertens (2014) 0.75

Left Ventricular Geometry on Transthoracic Echocardiogram and Prognosis after Lacunar Stroke: The SPS3 Trial. J Stroke Cerebrovasc Dis (2015) 0.75

The relevance of living supports on antiplatelet adherence and trial participation: the SPS3 trial. Int J Stroke (2014) 0.75

Morphological classification of penetrating artery pontine infarcts and association with risk factors and prognosis: The SPS3 trial. Int J Stroke (2016) 0.75